Our Journey

The Year 2021 is a defining milestone on our journey so far. It marks the 20th anniversary of GVK BIO’s resilient growth story and its transformation into Aragen, a trusted R&D and manufacturing partner to the global life sciences industry. With Aragen, we unveil a new brand identity, an inspiring purpose, and a promise to customers: Together Ahead

“Inspired by our purpose ‘In every molecule is the possibility for better health’, we look forward to shaping Aragen into a partner of choice for the life sciences industry.” – D S Brar

“GVK BIO’s legacy is the perfect springboard to launch Aragen into the next orbit of growth. Keeping customers ahead in the race for better health is our goal and Aragen is well-positioned to deliver.” – G V Sanjay Reddy

Our Journey

  • GVK BIO is rebranded Aragen in May, 2021
  • Goldman Sachs invests in Aragen
  • Discovery Services expand at Mallapur R&D Campus to include a state-of-the-art Compound Management Unit
  • Asia’s Best Employer Brand Award from World HRD Congress
  • Best-of-Breed COVID Champion Award from National HR Development Network, in recognition of exemplary work during the pandemic
  • GVK BIO becomes a Great Place to Work–Certified™ organization
  • Formulation Development Center added to Mallapur R&D Campus
  • Aragen Bioscience expands Biologics Labs
  • Analytical Development Labs inaugurated at Mallapur R&D Campus
  • Second Manufacturing Facility at Visakhapatnam, India commences production
  • Inogent Laboratories merges with GVK BIO
  • eCule, India’s first mobile app for Discovery Solutions, launched
  • Aragen Bioscience Vivarium receives AAALAC accreditation
  • Fine Chemical Manufacturing Plant setup in Hyderabad
  • GVK BIO establishes third R&D Campus in Bengaluru. Chemistry operations begin
  • ChrysCapital invests in GVK BIO
  • GVK Informatics spins off into an independent entity, Excelra – a Data Structuring and Analytical Solutions Company
  • Aragen Bioscience begins operations at a new Vivarium in Morgan Hill, CA
  • Formulation Development Labs established in Bengaluru, India
  • Second R&D Campus inaugurated at Mallapur, Hyderabad. Discovery and Development operations commence
  • GVK BIO acquires Aragen Bioscience Inc., a US-based preclinical CRO specializing in high value biologics services
  • Inogent Manufacturing Facility receives USFDA, EU and KFDA approval
  • India’s largest Isotope Labeling Facility established in Hyderabad
  • Expansion into Early Development and Scale-up
  • Inogent Manufacturing Facility receives PMDA approval
  • Nacharam Vivarium receives AAALAC accreditation
  • Chemistry, Biology and Integrated Discovery Services expand to more therapeutic areas
  • First Integrated Discovery Program begins
  • Fine Chemical Development added to the portfolio
  • Sequoia Capital invests in GVK BIO
  • Manni Kantipudi joins as President (now, Director and CEO)
  • Wyeth-dedicated Discovery Chemistry Research Center inaugurated
  • Biology Services added to solutions offering
  • Strategic partnership with Wyeth Research to establish a dedicated Discovery Chemistry Research Center at Nacharam
  • Manufacturing Unit acquired in Nacharam, Hyderabad (named Inogent Laboratories), which eventually expands into an integrated R&D Campus for Discovery, Development and Manufacturing Solutions
  • D S Brar joins as Co-Promoter and Chairman
  • Clinical Pharmacology operations begin
  • The Company expands into Chemistry Services and signs first FTE contract
  • G V Sanjay Reddy establishes GVK BIO as an Informatics Company, on April 02, 2001, in Hyderabad, India